MyChart Tool for Type 1 Diabetes Care

Overseen By Saunya Dover, MSc

Age: < 18

Sex: Any

Trial Phase: Academic

Sponsor: Children's Hospital of Eastern Ontario

Disqualifiers: Age ≥ 11, Non-English, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

200 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

How does the MyChart Tool for Type 1 Diabetes Care differ from other treatments?

The MyChart Tool for Type 1 Diabetes Care is unique because it focuses on enhancing self-management skills through an eHealth platform, allowing patients to adapt their insulin doses to everyday situations, which can help prevent complications. This approach is distinct from traditional treatments that may not emphasize patient autonomy and real-time management adjustments. ^{1 2 3 4 5}

What is the purpose of this trial?

Evolving technology and clinical innovation have led to dramatic changes in the management of type 1 diabetes (T1D). These changes have led to a need to collect a growing number of details from families during their visits. As a result, much of the physician-patient visit is spent transferring information instead of focusing on diabetes care, contributing to increased time pressures in clinic and unmet needs for patients. In response to this reality, the investigators have developed a tool that allows families to input their diabetes-related information into their physicians' electronic health record (EHR) documentation tool before their clinic visit, using a questionnaire administered via CHEO's secure patient portal (MyChart®). The investigators will evaluate the impact of an integrated electronic patient questionnaire, on quality of care (patient-reported), diabetes control and clinic efficiency. The investigators hope that our study will determine whether having families input clinical data prior to a visit is an effective strategy to improve the quality of diabetes care. The investigators believe that the findings will be of interest to all those studying the value of incorporating patient-entered data both within diabetes care and beyond.

Eligibility Criteria

This trial is for children under 11 years old with Type 1 Diabetes. They must be fluent in English and able to give consent. It's not open to those followed in Eating Disorder or Child and Youth Protection Clinics, or kids who are 11 or older.

Inclusion Criteria

I have been diagnosed with Type 1 Diabetes.

I am younger than 11 years old.

Exclusion Criteria

Patients unable or unwilling to provide consent and/or assent

I am 11 years old or older.

I am not fluent in English to follow all study procedures.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants in the intervention group complete the MyChart questionnaire prior to clinic visits

12 months

Regular clinic visits with pre-visit questionnaire

Control

Participants in the control group receive standard clinical care without the MyChart questionnaire

12 months

Regular clinic visits

Follow-up

Participants are monitored for quality of care and glycemic control outcomes

12 months

Treatment Details

Interventions

• MyChart Questionnaire

Trial Overview The study tests a MyChart Questionnaire that lets families enter diabetes-related info into their doctor's records before the clinic visit. The goal is to see if this improves care quality, diabetes control, and clinic efficiency.

Participant Groups

Group I: MyChart Questionnaire (Intervention Group) Experimental Treatment 1 Intervention

Participants within the intervention group will complete the patient-facing EHR-enabled MyChart® questionnaire.

Group II: Standard Clinical Care (Control Group) Active Control 1 Intervention

Participants within the control group will undergo standard clinical care with no study intervention.

Who Is Running the Clinical Trial?

Children's Hospital of Eastern Ontario

Lead Sponsor

Trials

134

Recruited

61,000+

Findings from Research

A pilot study involving 35 participants with type 1 diabetes demonstrated that a user-centered eHealth tool for functional insulin therapy (FIT) was well accepted and positively impacted learning outcomes.

The study found strong correlations between users' success in learning tasks and their perceived utility, educational adequacy, and ease of use of the tool, suggesting it effectively supports self-management skills in diabetes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

User-centered approach in the development of an eHealth tool for self-management skills in functional insulin therapy to prevent complications of diabetes. Fezzi, C., Refahi, H., Albuisson, E., et al.[2022]

The New-Onset Diabetes Educator (NODE) web application significantly improved diabetes knowledge among child/caregiver dyads, with post-intervention scores showing a medium effect size (Δ=0.56) compared to standard education methods.

NODE was found to be user-friendly and feasible, suggesting it could be an effective tool for enhancing diabetes self-management education at the time of diagnosis, potentially leading to better long-term health outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

New-Onset Diabetes Educator to Educate Children and Their Caregivers About Diabetes at the Time of Diagnosis: Usability Study. Bernier, A., Fedele, D., Guo, Y., et al.[2023]

References

1. United States pubmed.ncbi.nlm.nih.gov

A review of measures of self-management of type 1 diabetes by youth and their parents. [2022]

2. United States pubmed.ncbi.nlm.nih.gov

User-centered approach in the development of an eHealth tool for self-management skills in functional insulin therapy to prevent complications of diabetes. [2022]

3. United States pubmed.ncbi.nlm.nih.gov

Feasibility of Routine Assessment of Exercise Knowledge and Safety in Youth With Type 1 Diabetes. [2020]

4. England pubmed.ncbi.nlm.nih.gov

A New Paediatric Diabetes Knowledge Test - M-WIKAD Development and Factor Analysis. [2023]

5. Canada pubmed.ncbi.nlm.nih.gov

New-Onset Diabetes Educator to Educate Children and Their Caregivers About Diabetes at the Time of Diagnosis: Usability Study. [2023]